NY-ESO-1 (CTAG1B) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI2B6]
SKU
TA500528AM
-
TrueMAB™
Antibodies made against full-length proteins as antigens.
Click here to learn more.
Product Data | |
Clone Name | OTI2B6 |
---|---|
Application | FC, IF, IHC, WB |
Recommended Dilution | WB 1:5000 IHC 1:50 IF 1:100 |
Reactivity | Human |
Antibody Host | Mouse |
Isotype | IgG1 |
Clonality | Monoclonal |
Immunogen | Full-length protein expressed in 293T cell transfected with human CTAG1B expression vector |
Buffer | PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. |
Concentration | 0.5 mg/ml |
Purification | Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) |
Conjugation | Biotin |
Storage | Store at -20°C as received. |
Stability | Stable for 12 months from date of receipt. |
Shipping | Blue Ice |
Predicted Protein Size | 18 kDa |
Gene Name | cancer/testis antigen 1B |
Database Link | |
Background | Cancer/testis antigens, such as CTAG1B, are expressed in a variety of malignant tumors but soley in testis among normal adult tissues (Yoshida et al., 2006 (PubMed 16596224)). |
Synonyms | CT6.1; CTAG; CTAG1; ESO1; LAGE-2; LAGE2B; NY-ESO-1 |
Reference Data | |
Protein Families | Druggable Genome |
Write Your Own Review
Product Manuals |
FAQs |
SDS |
Antibody Resources |
SKU | Description | Size | Price | |
---|---|---|---|---|
CF500528 | Carrier-free (BSA/glycerol-free) CTAG1B (NY-ESO-1) mouse monoclonal antibody, clone OTI2B6 (formerly 2B6) | 100 ug |
$600.00
|
|
TA500528 | Anti-CTAG1B (NY-ESO-1) mouse monoclonal antibody, clone OTI2B6 (formerly 2B6) | 100 ul |
$447.00
|
|
TA500528BM | 100 ul |
$509.00
|
|
|
TA500528S | Anti-CTAG1B (NY-ESO-1) mouse monoclonal antibody, clone OTI2B6 (formerly 2B6) | 30 ul |
$200.00
|
|
Citations
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.